Vascular risk and Ab interact to reduce cortical thickness in AD vulnerable brain regions

Neurology

Volumn 83, Issue 1, 2014, Pages 40-47

  Villeneuve, Sylvia ^a   Reed, Bruce R ^b   Madison, Cindee M ^a   Wirth, Miranka ^a   Marchant, Natalie L ^c   Kriger, Stephen ^d   Mack, Wendy J ^e   Sanossian, Nerses ^e   DeCarli, Charles ^b   Chui, Helena C ^e   Weiner, Michael W ^d   Jagust, William J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; PITTSBURGH COMPOUND B; 2 (4' (METHYLAMINO)PHENYL) 6 HYDROXYBENZOTHIAZOLE; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; ANILINE DERIVATIVE; DIAGNOSTIC AGENT; THIAZOLE DERIVATIVE;

AGED; ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN REGION; BRAIN SCINTISCANNING; CONTROLLED STUDY; CORONARY RISK; CORTICAL THICKNESS (BRAIN); FEMALE; FRAMINGHAM RISK SCORE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN INTERACTION; BRAIN; CHI SQUARE DISTRIBUTION; LONGITUDINAL STUDY; METABOLISM; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; RISK FACTOR; SCINTISCANNING; VASCULAR DISEASE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; BRAIN; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS; THIAZOLES; VASCULAR DISEASES;

EID: 84904011912     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000550     Document Type: Article

References (36)

1. Kalaria RN, Akinyemi R, Ihara M. Does vascular pathology contribute to Alzheimer changes? J Neurol Sci 2012; 322: 141-147.
2. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004;62: 1148-1155.
3. Reed B, Villeneuve S, Mack W, Decarli C, Chui HC, Jagust W. Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol 2014;71: 195-200.
4. Reed BR, Marchant NL, Jagust WJ, DeCarli CC, Mack W, Chui HC. Coronary risk correlates with cerebral amyloid deposition. Neurobiol Aging 2012;33: 1979-1987.
5. Langbaum JB, Chen K, Launer LJ, et al. Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons. Neurobiol Aging 2012;33: 827.e11-827.e19.
6. Rodrigue KM, Rieck JR, Kennedy KM, Devous MD, Diaz-Arrastia R, Park DC. Risk factors for beta-amyloid deposition in healthy aging: vascular and genetic effects. JAMA Neurol 2013;70: 600-606.
7. Marchant NL, Reed BR, DeCarli CS, et al. Cerebrovascular disease, beta-amyloid, and cognition in aging. Neurobiol Aging 2012;33: 1006.e25-1006.e36.
8. Launer LJ, Hughes TM, White LR. Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol 2011;70: 774-780.
9. Buckner RL. Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 2004;44: 195-208.
10. Villeneuve S, Reed BR, Wirth M, et al. Cortical thickness mediates the effect of beta-amyloid on episodic memory. Neurology 2014;82: 761-767.
11. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97: 1837-1847.
12. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis: I: segmentation and surface reconstruction. Neuroimage 1999;9: 179-194.
13. Mormino EC, Brandel MG, Madison CM, et al. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage 2012;59: 1152-1160.
14. Hayasaka S, Nichols TE. Validating cluster size inference: random field and permutation methods. Neuroimage 2003;20: 2343-2356.
15. Cardenas VA, Reed B, Chao LL, et al. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke 2012;43: 2865-2870.
16. Leritz EC, Salat DH, Williams VJ, et al. Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults. Neuroimage 2011;54: 2659-2671.
17. Seo SW, Lee JM, Im K, et al. Cardiovascular risk factors cause cortical thinning in cognitively impaired patients: relationships among cardiovascular risk factors, white matter hyperintensities, and cortical atrophy. Alzheimer Dis Assoc Disord 2012;26: 106-112.
18. Ward MA, Bendlin BB, McLaren DG, et al. Low HDL cholesterol is associated with lower gray matter volume in cognitively healthy adults. Front Aging Neurosci 2010;2: 29.
19. Wolf H, Hensel A, Arendt T, Kivipelto M, Winblad B, Gertz HJ. Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol 2004;56: 745-748.
20. Kim CH, Seo SW, Kim GH, et al. Cortical thinning in subcortical vascular dementia with negative (11)C-PiB PET. J Alzheimers Dis 2012;31: 315-323.
21. Walshe TE, D'Amore PA. The role of hypoxia in vascular injury and repair. Annu Rev Pathol 2008;3: 615-643.
22. de la Torre JC. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol 2012;2012: 367516.
23. Marsche G, Saemann MD, Heinemann A, Holzer M. Inflammation alters HDL composition and function: implications for HDL-raising therapies. Pharmacol Ther 2012;137: 341-351.
24. Bandeali S, Farmer J. High-density lipoprotein and atherosclerosis: the role of antioxidant activity. Curr Atheroscler Rep 2012;14: 101-107.
25. Bowman GL, Kaye JA, Quinn JF. Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease. Curr Gerontol Geriatr Res 2012;2012: 184042.
26. Dickerson BC, Stoub TR, Shah RC, et al. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 2011;76: 1395-1402.
27. Dickerson BC, Bakkour A, Salat DH, et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 2009;19: 497-510.
28. Reiman EM, Chen K, Langbaum JB, et al. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging. Neuroimage 2010;49: 169-176.
29. Chui HC, Zheng L, Reed BR, Vinters HV, Mack WJ. Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther 2012;4: 1.
30. Launer LJ, Petrovitch H, Ross GW, Markesbery W, White LR. AD brain pathology: vascular origins? Results from the HAAS Autopsy Study. Neurobiol Aging 2008; 29: 1587-1590.
31. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367: 795-804.
32. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am J Psychiatry 2002;159: 738-745.
33. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9: 119-128.
34. Jack CR Jr, Knopman DS, Weigand SD, et al. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol 2012;71: 765-775.
35. Maillard P, Seshadri S, Beiser A, et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol 2012;11: 1039-1047.
36. Ford ES, Giles WH, Mokdad AH. The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol 2004; 43: 1791-1796.